Zobrazeno 1 - 10
of 112
pro vyhledávání: '"J J, Huart"'
Publikováno v:
Vox Sanguinis. 104:275-291
‘Safe blood’ is and has always been the major concern in transfusion medicine. Plasma can undergo virus inactivation treatments based on physicochemical, photochemical or thermal methodologies for pathogen inactivation. The validation of these tr
Autor:
F. Schooneman, J.-J. Huart, T. Verpoort, Daniela Bratosin, F. Goudaliez, L. Mitrofan-Oprea, Carmen Palii, A. Héron, M. Behague, E. Smagghe, Jean-Pierre Tissier, Jean Montreuil
Publikováno v:
Transfusion Clinique et Biologique. 14:393-401
Resume Les recherches que nous avons effectuees ont pour but d’elucider le probleme de la rapide clairance des hematies transfusees en nous fondant sur nos connaissances actuelles des mecanismes de la mort programmee de ces cellules. Materiels et m
Publikováno v:
Journal of Chromatography B. 790:199-207
Protein C deficiency (inherited and acquired) has a relatively high incidence rate in the general population worldwide. For many years, protein C deficient patients have been treated with fresh frozen plasma, prothrombin complex concentrates, heparin
Publikováno v:
Transfusion Clinique et Biologique. 22:260-261
Contexte Une nouvelle technique de phenotypage etendu pour la qualification biologique des dons utilise une gamme de reactifs prets a l’emploi (Diagast) pour la determination des antigenes Fya, Fyb, Jka, Jkb, S, s, sur automate a haute cadence PK73
Autor:
Jérôme Estaquier, J.-J. Huart, Joël Mazurier, David Aminoff, Jean Montreuil, Jean-Claude Ameisen, Daniela Bratosin, Jean-Pierre Tissier
Publikováno v:
Biochimie. 80:173-195
Human red blood cells (RBCs) have a life-span of 120 days in circulation, after which they are phagocytized by resident macrophages. Extensive studies have been undertaken by many investigators in order to elucidate the cellular and molecular mechani
Publikováno v:
Vox sanguinis. 104(4)
'Safe blood' is and has always been the major concern in transfusion medicine. Plasma can undergo virus inactivation treatments based on physicochemical, photochemical or thermal methodologies for pathogen inactivation. The validation of these treatm
Publikováno v:
Revue Française de Transfusion et d'Hémobiologie. 36:93-102
The approach followed in the design of a large-scale pasteurization treatment (60 degrees C for 10 hours in the liquid state) of fresh frozen plasma is presented. Various aspects thought to influence the viral safety of such a product are discussed.
Publikováno v:
Vox Sanguinis. 60:8-15
A new ion-exchange chromatographic procedure has been developed to produce a highly purified factor VIII (FVIII) concentrate from plasma cryoprecipitate. Solubilized cryoprecipitate, after adsorption on aluminium hydroxide and cold precipitation, was
Publikováno v:
Vox Sanguinis. 58:77-84
A fibrin glue preparation has been obtained from pooled human plasma using a procedure which includes a solvent-detergent (SD) treatment to inactivate lipid-enveloped viruses. The SD treatment inactivated greater than or equal to 5.5 log10 of HIV in